Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. As 703026
2. As-703026
3. As703026
4. Msc-1236369b
5. N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide
1. 1236699-92-5
2. As703026
3. As-703026
4. Pimasertib (as-703026)
5. As 703026
6. Msc1936369b
7. 1204531-26-9
8. Msc-1936369
9. 6on9rk82al
10. Msc1936369a
11. Msc-1936369a
12. Sar 245509
13. Emd 1036239
14. Emd-1036239
15. (s)-n-(2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)isonicotinamide
16. 4-pyridinecarboxamide, N-((2s)-2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)-
17. N-((2s)-2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)pyridine-4-carboxamide
18. N-[(2s)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodo-anilino)pyridine-4-carboxamide
19. N-[(2s)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]pyridine-4-carboxamide
20. G-02443714
21. (s)-n-(2,3-dihydroxypropyl)-3-(2-fluoro-4-iodophenylamino)isonicotinamide
22. (s)-n-(2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)isonicotinamide.
23. 4-pyridinecarboxamide, N-[(2s)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-
24. Pimasertib [inn]
25. Pimasertib [usan:inn]
26. Unii-6on9rk82al
27. N-[(2s)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide
28. Pimasertib (usan/inn)
29. Pimasertib [usan]
30. Pimasertib; As703026
31. N-[(2s)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-4-pyridinecarboxamide
32. Pimasertib [who-dd]
33. Mls006010177
34. Gtpl7872
35. Schembl2720659
36. Chembl2107832
37. Chebi:94793
38. Dtxsid40152870
39. Ex-a403
40. Bcpp000386
41. Bcp02094
42. Bdbm50014412
43. Nsc755763
44. Nsc800854
45. Zinc38226009
46. Akos022186348
47. Bcp9000325
48. Ccg-269018
49. Cs-0198
50. Db14904
51. Nsc-755763
52. Nsc-800854
53. Ncgc00346530-01
54. Ac-32862
55. As-16324
56. Hy-12042
57. Smr004701285
58. As703026,msc1936369b
59. Sw219691-1
60. C71933
61. D10426
62. A857420
63. J-523298
64. Brd-k89014967-001-01-9
65. Q27088393
66. As7030261236699-92-5
67. As-703026;n-[(2s)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-4-pyridinecarboxamide;as-703026
| Molecular Weight | 431.20 g/mol |
|---|---|
| Molecular Formula | C15H15FIN3O3 |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 431.01422 g/mol |
| Monoisotopic Mass | 431.01422 g/mol |
| Topological Polar Surface Area | 94.5 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 391 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
97
PharmaCompass offers a list of Pimasertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pimasertib manufacturer or Pimasertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pimasertib manufacturer or Pimasertib supplier.
PharmaCompass also assists you with knowing the Pimasertib API Price utilized in the formulation of products. Pimasertib API Price is not always fixed or binding as the Pimasertib Price is obtained through a variety of data sources. The Pimasertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pimasertib (AS-703026) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pimasertib (AS-703026), including repackagers and relabelers. The FDA regulates Pimasertib (AS-703026) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pimasertib (AS-703026) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pimasertib (AS-703026) supplier is an individual or a company that provides Pimasertib (AS-703026) active pharmaceutical ingredient (API) or Pimasertib (AS-703026) finished formulations upon request. The Pimasertib (AS-703026) suppliers may include Pimasertib (AS-703026) API manufacturers, exporters, distributors and traders.
Pimasertib (AS-703026) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pimasertib (AS-703026) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pimasertib (AS-703026) GMP manufacturer or Pimasertib (AS-703026) GMP API supplier for your needs.
A Pimasertib (AS-703026) CoA (Certificate of Analysis) is a formal document that attests to Pimasertib (AS-703026)'s compliance with Pimasertib (AS-703026) specifications and serves as a tool for batch-level quality control.
Pimasertib (AS-703026) CoA mostly includes findings from lab analyses of a specific batch. For each Pimasertib (AS-703026) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pimasertib (AS-703026) may be tested according to a variety of international standards, such as European Pharmacopoeia (Pimasertib (AS-703026) EP), Pimasertib (AS-703026) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pimasertib (AS-703026) USP).
